Psychedelics CURED My Alcoholism
RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober.
Psychedelics CURED...
ClearMind’s (CMND) MEAI and Reducing Alcohol Use.
Amazing New Technologies Keep Popping up.
We love when this happens during Sector Bear Markets, which Psychedelics have...
Jose Manuel Calderon Joins Hapbee (HAPB).
Prominent athlete participates in Private Placement and will contribute to Hapbee's expansion in global sports.
ABVC BioPharma (ABVC) up 160% on News
And the Day-Traders Say, I'll Drink to That!
LIVE QUOTE
Adial Pharmaceuticals (ADIL) Announces Closing of $4 Million Private Placement Priced At-The-Market.
CHARLOTTESVILLE, Va., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on...
Adial (ADIL). Don’t Give up Drinking. Just Drink Less!
Hmm, Now Here's a Novel Idea and Every Heavy Drinkers Dream!
Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies...
Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC TenX Keane (TENK). Shares...
We Would Define This as Huge News..
Citius Pharma would receive 67.5...
Ardelyx (ARDX) $3.40, Receives FDA Approval.
BooYah, Ardelyx shoots and we score (again) last week..but wait, there's more!
It trades down post-approval as short-term...
Adding Dolphin Entertainment (DLPN) to the Watch List
Dolphin's (DLPN) $1.76 Earnings Call and Investor Deck.
Amazing Company whose beatdown has been UNWARRANTED. Current price offers an...
Adding Paramount (PARA) $12 to the Watch List.
When is Enough, Enough?
Adding to the Watch List and we're betting on a sale of the streaming...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
